Brain Metastases
Brain metastases occur when cancer cells spread to the brain from other parts of the body, leading to various neurological symptoms and complications.
Colorectal Cancer: SGM-101 Imaging Study
We are testing a new imaging agent to help surgeons detect brain metastases from colorectal cancer during surgery. This study aims to see how well it works and its safety for patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have brain metastasis from colorectal cancer and are you scheduled for surgery?
- Are you currently pregnant or breastfeeding?
- Have you had any severe allergic reactions in the past?
- Have you been diagnosed with any other cancers in the last 5 years, except for certain skin cancers?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sgm-101
Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Leids Universitair Medisch Centrum (LUMC)
Surgery
Leiden, Netherlands
Haaglanden Medisch Centrum Stichting
Surgery
Voorburg, Netherlands
Sponsor: Academisch Ziekenhuis Leiden
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.